IRIS
DEROSA, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.755
EU - Europa 10.310
AS - Asia 8.195
AF - Africa 29
SA - Sud America 19
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 15
Totale 32.339
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.595
CN - Cina 8.008
IE - Irlanda 2.931
UA - Ucraina 2.499
FI - Finlandia 1.416
DE - Germania 1.381
SE - Svezia 765
IT - Italia 743
GB - Regno Unito 303
CA - Canada 146
FR - Francia 90
SG - Singapore 48
IN - India 47
NL - Olanda 41
RU - Federazione Russa 40
IR - Iran 30
BE - Belgio 18
GR - Grecia 17
MU - Mauritius 17
EU - Europa 15
IQ - Iraq 15
JP - Giappone 15
RO - Romania 15
MX - Messico 13
NZ - Nuova Zelanda 12
ES - Italia 11
CH - Svizzera 9
TR - Turchia 9
CZ - Repubblica Ceca 7
EG - Egitto 7
JO - Giordania 6
MK - Macedonia 6
PE - Perù 6
CO - Colombia 5
DZ - Algeria 5
PK - Pakistan 5
AU - Australia 4
BR - Brasile 4
CL - Cile 3
HU - Ungheria 3
RS - Serbia 3
TH - Thailandia 3
AT - Austria 2
EE - Estonia 2
HK - Hong Kong 2
LV - Lettonia 2
PL - Polonia 2
SI - Slovenia 2
BG - Bulgaria 1
BH - Bahrain 1
CY - Cipro 1
DO - Repubblica Dominicana 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
VE - Venezuela 1
YE - Yemen 1
Totale 32.339
Salva come PNG Salva come JPEG
Città #
Jacksonville 3.394
Dublin 2.931
Chandler 2.846
Nanjing 2.508
Nanchang 1.091
Ashburn 823
Princeton 807
Shenyang 758
Hebei 702
Lawrence 700
Changsha 664
Wilmington 655
Jiaxing 571
Medford 521
Hangzhou 426
Tianjin 414
Boardman 366
Beijing 283
Helsinki 242
Ann Arbor 138
Milan 132
Toronto 123
Shanghai 115
Woodbridge 115
Norwalk 111
Seattle 105
Fairfield 78
Kunming 66
Des Moines 61
Jinan 60
Cambridge 54
New York 51
Ningbo 51
Verona 40
Pavia 38
Zhengzhou 35
Los Angeles 30
Orange 30
Pune 27
Guangzhou 25
Eindhoven 24
Singapore 24
Rome 22
Bruino 19
Genova 18
Lanzhou 18
Taizhou 18
Brussels 16
Piscataway 16
Redwood City 16
Washington 16
Dearborn 15
Fuzhou 15
Magenta 14
Baghdad 13
Changchun 13
Tokyo 13
San Francisco 12
Houston 10
Timisoara 10
Bologna 8
Falkenstein 8
Leawood 8
Quzhou 8
Redmond 8
Tappahannock 8
West Jordan 8
Moscow 7
Paris 7
Rotterdam 7
Vancouver 7
Amman 6
Berlin 6
Borås 6
Brno 6
Haikou 6
Lima 6
Walnut 6
Zurich 6
Auburn Hills 5
Auckland 5
Bogotá 5
Brescia 5
Caccamo 5
Chicago 5
Mumbai 5
Novokuznetsk 5
Palermo 5
Rozzano 5
Skopje 5
Alcobendas 4
Andover 4
Bergamo 4
Buffalo 4
Collegno 4
Genoa 4
Giza 4
Halifax 4
Isernia 4
Kochi 4
Totale 22.736
Salva come PNG Salva come JPEG
Nome #
Effetto del lactobacillus paracasei I1688 e del lactobacillus salivarius I1794 (psmix®) sui lipidi ematici nell’ipercolesterolemia lieve 313
Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial 146
A randomized, placebo-controlled study about the effect of a nutraceutical combination of red yeast rice, silybum marianum and octasonol on lipid profile, endothelial and inflammatory parameters 121
Impaired respiratory function reduces haemoglobin oxygen affinity in COVID-19 110
Diagnostico y Tratamiento de los desordenes lipidicos. Mc Graw Hill Education 2014. 93
Comparison between diet, orlistat and fluvastatin in obese patients with mild hypertension and hypercholesterolemia 84
Comparison between orlistat and sibutramine in obese patients with type 2 diabetes mellitus 83
Confronto tra dieta, orlistat e fluvastatina in soggetti obesi, con ipertensione arteriosa lieve e ipercolesterolemia 77
Effects of berberis aristata/silybum marianum association on metabolic parameters and adipocytokines in overweight dyslipidemic patients 77
Effect of valsartan or olmesartan addition to amlodipine/hydrochlorotiazide combination on 24 hour blood pressure reduction in essential hypertension 75
Diarrea in paziente diabetico 75
Differential effect of candesartan and olmesartan on adipose tissue activity biomarkers in type 2 diabetic hypertensive patients 74
Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes 73
A possible way to improve the glycemic control and the beta cell function during three years: the triple therapy. 73
Comparison between exenatide and glimepiride on metabolic control and on insulin resistance in type 2 diabetic patients with metformin therapy 72
Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria 70
A multicenter, randomised, single-blind study on the effects of exenatide or glimepiride on insulin resistance. 70
Azione della moxonidina sul metabolismo glucidico e lipidico negli ipertesi con sindrome metabolica 70
Matrix metalloproteinase 2 may be a marker of microangiopathy compared to metalloproteinase 9 in children and adolescents with type 1 diabetes mellitus: A 5 year follow-up study 70
Confronto tra nateglinide più metformina rispetto a glibenclamide più metformina sul metabolismo glucidico nei pazienti diabetici di tipo 2: studio ad 1 anno 70
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 69
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 69
Confronto tra pioglitazone e rosiglitazone sul metabolismo glucidico e lipidico nei soggetti diabetici di tipo 2 in terapia con metformina 69
Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study 68
Are there light and serious metabolic syndromes? The need for a graded diagnosis. 68
Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome 67
Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus 67
n-3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia 67
Alkaloids in the nature: pharmacological applications in clinical practice of berberine and mate tea. 66
Association between low-molecular weight apolipoprotein(a) isoforms and obesity in Italian women 65
Confronto tra l'effetto anti-proteinurico dell'associazione telmisartan/amlodipina rispetto a losartan/amlodipina nel paziente con diabete di tipo 2, iperteso e microalbuminurico 65
Effects of losartan and amlodipine alone or combined with simvastatin in hypertensive patients with nonalcoholic hepatic steatosis 65
Actions of glimepiride plus metformin compared to rosiglitazone plus metformin on glucose metabolism, fibrinolytic, and coagulation measurements in Type 2 diabetic patients. 65
Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients 64
Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients 64
Different actions of losartan and ramipril on adipose tissue Activity and vascular remodeling biomarkers in hypertensive patients 64
Il controllo del paziente dislipidemico 64
n-3 PUFAs on metalloproteinases, inflammatory and insulin resistance parameters in dyslipidemic patients after euglycemic clamp and oral fat load. 64
Comparison between orlistat and sibutramine in obese patients with mild hypertension 63
Prevenzione della malattia coronarica: il rischio cardiovascolare globale 63
Sitagliptin added to previously taken anti-diabetic agents on insulin resistance and lipid profile: a two years study evaluation. 63
Effects of rosiglitazone alone and in association with simvastatin on lipid and lipoprotein parameters in patients with metabolic syndrome 63
Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load 63
Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome 62
Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients 62
Comparison between fosinopril and eprosartan on lipid profile and Lp(a) in normotensive, type 2 diabetic subjects, with microalbuminuria 62
Prognostic value of dypiridamole stress echocardiography for detection of silent myocardial ischemia in asymptomatic diabetic patients. 62
Changes during glimepiride plus rosiglitazone vs glibenclamide plus rosiglitazone treatment on glucose metabolism and lipoprotein (a) in Type 2 diabetic patients. 62
Matrix metalloproteinase-2 activity (MMP-2) in children and adolescents with type 1 diabetes mellitus: Follow-up study 62
Aerobic physical activity in obese subjects compared to anaerobic/aerobic physical activity 62
A comparison between sitagliptin or glibenclamide in addition to metformin+pioglitazone on glycemic control and beta-cell function: the triple oral therapy 62
Effects of berberine on lipid profile in subjects with low cardiovascular risk 62
Long-term predictors of impaired fasting glucose and type 2 diabetes in subjects with family history of type 2 diabetes: A 12-years follow-up of the Brisighella Heart Study historical cohort. 62
Comparison between perindopril and candesartan in hypertensive patients with type 2 diabetes: evaluation of lipid profile and Lp(a) 62
Effect of losartan irbesartan and candesartan on platelet aggregability and fibrinolysis in type 2 diabetic hypertensive patients 61
Effects of sibutramine plus L-carnitine compared to sibutramine on inflammatory parameters in type 2 diabetic patients 61
Vildagliptin added to metformin on β-cell function after an euglycemic hyperinsulinemic and hyperglycemic clamp in type 2 diabetic patients. 61
Coenzyme Q10 effect on the serum creatinine increase associated to rosuvastatin 20 mg in severe hypercholesterolemic patients 61
The efficacy and safety of pioglitazone or rosiglitazone added onto metformin on diabetic dyslipidemia 61
Berberis aristata/silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients 61
Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses. 61
Effect of manidipine-rosuvastatin combination on fibrinolysis, inflammation markers and insulin sensitivity in hypertensive hypercholesterolemic patients 61
Dietary habits in type II diabetes mellitus: how is adherence to dietary recommendations? 61
Effect of Fosinopril on blood pressure, lipid profile and lipoprotein (a) in normotensive patients with type 2 diabetes and microalbuminuria: open-label, uncontrolled study 60
Canrenone on cardiovascular mortality in congestive heart failure: CanrenOne eFFects on cardiovascular mortality in patiEnts with congEstIve hearT failure: The COFFEE-IT study 60
Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation 60
Effects of aliskiren on QT duration and dispersion in hypertensive patients with type 2 diabetes mellitus 60
Dipyridamole echocardiography for detection of angiographically assessed coronary artery disease in asymptomatic type 2 diabetic patients: preliminary results of the SEDIA trial 60
Acarbose compared to placebo on insulin resistance biomarkers in a double-blind, placebo-controlled trial 60
Comparison between glimepiride plus pioglitazone vs. glimepiride plus rosiglitazone on glucose metabolism and on lipid, lipoprotein and apolipoprotein fractions in type 2 diabetic patients 60
Azione della moxonidina sul metabolismo glucidico e lipidico negli ipertesi con sindrome metabolica 60
La terapia delle dislipidemie come fattore di rischio cardiovascolare 60
Berberis aristata/Silybum marianum fixed combination (Berberol®) effects on lipid profile in dyslipidemic patients intolerant to statins at high dosages: A randomized, placebo-controlled, clinical trial. 60
La doxazosina migliora i parametri pressori e l'assetto metabolico nei soggetti intolleranti al glucosio in terapia con acarbose 60
Differential effect of glimepiride and rosiglitazone on metabolic control of type 2 diabetic patients treated with metformin: a randomized, double-blind, clinical trial 59
Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin 59
Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride 59
Atorvastatin addition to losartan or to atenolol and recurrence of paroxysmal atrial fibrillation in hypertension 59
Fosinopril vs eprosartan in normotensive, Type 2 diabetic patients, with microalbuminuria 59
Effect of losartan irbesartan and candesartan on platelet aggregability and fibrinolysis in type 2 diabetic hypertensive patients 59
Psyllium improves dyslipidaemia, hyperglycaemia and hypertension, while guar gum reduces body weight more rapidly in patients affected by metabolic syndrome following an AHA Step 2 diet 59
Metalloproteasi-2, metalloproteasi-9 ed inibitore tissutale delle metalloproteasi-1 in pazienti ipertesi 59
Differenti effetti di candesartan e olmesartan sui parametri di attività del tessuto adiposo in pazienti diabetici di tipo 2 ipertesi 59
L’ecocardiografia da stress con dipiridamolo per la scoperta della cardiopatia ischemica valutata angiograficamente nei pazienti diabetici di tipo 2 asintomatici: risultati preliminari dello studio SEDIA (Stress Echo in DIAbetes) 59
Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with euglycemic clamp and oral fat load 59
Effetti metabolici di telmisartan e irbesartan nei pazienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone 59
Olmesartan/amlodipine combination vs olmesartan or amlodipine monotherapies on blood pressure and insulin resistance in a sample of hypertensive patients 59
Hypoglycemia, its implications in the clinical practice, and possible ways to prevent it. 59
Pioglitazone plus glimepiride: a promising alternative in metabolic control 59
Intervento multi-fattoriale di riduzione del rischio cardio-vascolare in pazienti con diabete tipo 2: risultati a due anni dello studio MIND-IT 59
Effetto della combinazione valsartan-amlodipina sulla funzione cognitiva in pazienti ipertesi anziani 59
Efficacy of fluvastatin together with fenofibrate in hypercholesterolemic type 2 diabetic subjects compared to monotherapy. 59
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial 59
Endothelial function, blood pressure control, and risk modification: impact of irbesartan alone or in combination 58
Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial 58
Anti-obesity drugs: a review about their effects and their safety 58
Effect of telmisartan and ramipril on arial fibrillation episodes recurrence and severity in hypertensive patients with metabolic syndrome and lone paroxysmal atrial fibrillation 58
Different effects of aliskiren and losartan on fibrinolysis and insulin sensitivity in hypertensive patients with metabolic syndrome 58
Effetti di un carico lipidico orale sui marcatori di infiammazione e stress endoteliale nei soggetti sani 58
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia during omega-3 polyunsaturated fatty acids therapy 58
Totale 6.819
Salva come PNG Salva come JPEG
Categoria #
all - tutte 115.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.651
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209.668 2.767 4.370 14 476 5 553 81 516 9 697 165 15
2020/20214.687 575 461 122 474 8 619 19 789 133 729 628 130
2021/20222.603 28 7 124 17 11 13 30 162 135 45 480 1.551
2022/20238.600 942 532 47 615 1.009 917 7 537 3.523 96 259 116
2023/20242.641 259 500 95 195 353 653 65 256 28 84 61 92
2024/202559 59 0 0 0 0 0 0 0 0 0 0 0
Totale 32.915